More Clinical Articles

Clinical

New Initiative Aims for “World Free of Cancer by 2050”

Ben Steele, (Jun 6, 2013)

A new initiative which aims for “a world free of cancer by 2050” has been launched in the US, stressing the need for more patient-centred innovation and an appreciation of the economic benefits of new cancer drugs.
Clinical

NICE’s War Against the Rising Cost of Innovation

Ben Steele, (Jun 5, 2013)

Ben Steele talks with Sarah Garner, Associate Director of R&D at NICE, about the rising cost of pharma R&D, and how NICE plans to combat this trend by examining the role of real world data in reducing the costs of innovation.
Clinical

New Research Holds Potential For Production Of Purer And Cheaper DNA Molecule Drug Versions

Lucy Brake, (Jun 5, 2013)

A novel way to mass produce specific DNA molecules is believed to hold the key for many of the challenges that come with current production methods. This ultimately means that high quality DNA molecules can be manufactured in large quantities at a cost effective price.
Clinical

Genetic ‘Editing’ Technique Results in the First Effective Form of Treatment for Duchenne Muscular Dystrophy

Anonymous, (Jun 5, 2013)

Patients with Duchenne muscular dystrophy could benefit from a unique genetic ‘editing’ technique which repairs the faulty gene safely.
Clinical

The European Parliament Votes in Favor on Trial Transparency Regulations

Zuzanna Fimińska, (Jun 4, 2013)

New European regulations will improve data transparency by requiring that detailed summaries be published in a publicly accessible EU database and imposing sanctions on sponsors who do not comply.
Clinical

Actress’ Decision Fuels Genetic Testing Debate

Louise Kelly, (Jun 3, 2013)

Angelina Jolie's announcement in May that she has taken the prophylactic measure of a double mastectomy has brought to the fore the on-going debate around affordability and accessibility over genetic testing.
Clinical

EATRIS Aims to Bridge Translational Gap in Europe’s Pharma Industry

Lucy Brake, (Jun 3, 2013)

The official launch of the European Advanced Translational Research Infrastructure in Medicine (EATRIS) at today’s inaugural conference aims to shorten the time from research to treatment by bringing together the world of scientific medical research and applications in the clinic.
Clinical

Patients Need More than Targeted Cancer Drug Crizotinib, Study Suggests

Anonymous, (Jun 3, 2013)

A breakthrough study displaying crizotinib resistance in a ROS1-positive lung tumour demonstrates the need to develop further alternative therapies for patients with advanced lung cancer.
Clinical

Patients could Benefit from a Breakthrough Tool to Evaluate the Impact of Nanomedicines

Anonymous, (May 30, 2013)

A revolutionary imaging technique could improve R&D, cost and quality of drugs by tracking the impact of nanomedicines on patients.
Clinical

Organisational Fears Act as a Barrier to Adaptive Clinical Trial Designs, Not Regulatory Bodies

Anonymous, (May 29, 2013)

Internal organisational resistance hinders the adoption of adaptive clinical trial designs, which could improve R&D performance, quality and cost, rather than regulatory agencies.

Pages